You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

Welcome to ADVENT!

What do you want to know about type 2 inflammatory diseases?

No matches

ADVENT is a medical education program designed to advance the understanding of type 2 inflammation. ADVENT is developed in collaboration with over 50 global experts and links the latest science of type 2 inflammation with the clinical experience to improve patient care.

Educational resources

Recommended for you

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

Pulmonology

17 min

expert video

ERS 2023 | The Impact of Type 2 Inflammation on COPD: Examining Its Role in Disease Pathophysiology

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Pulmonology

29 min

expert video

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Gastroenterology

5 min

interactivity

Piecing Together the Puzzle in Patients With EoE

Gastroenterology

5 min

Infographic

Adaptive Behaviors in EoE Infographic

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Gastroenterology

17 min

audio

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Gastroenterology

6 min

expert video

Assessing EoE: Assessing Symptoms in Patients With EoE

Dermatology

42 min

expert video

Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Dermatology

5 min

Infographic

The Burden of AD: More Than Skin Deep

The Benefits of Early Intervention in AD: More Than Skin Deep

Dermatology

82 min

expert video

The Benefits of Early Intervention in AD: More Than Skin Deep

Recently added

Pulmonology

22 min

audio

ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond

Pulmonology

14 min

Infographic

ADVENT On Air | Charting a New Course: The Frontier of Early Intervention and Disease Modification in AD

What Are the Key Inflammatory Processes in Patients with COPD?

Pulmonology

2 min

expert video

What Are the Key Inflammatory Processes in Patients with COPD?

Type 2 Inflammation

1 min

expert video

Disease Modification Concepts in AD

What do we mean by disease control in AD?

Dermatology

3 min

expert video

What do we mean by disease control in AD?

Popular in United States

What Do We Know About Type 2 Inflammation in COPD?

Pulmonology

1 min

expert video

What Do We Know About Type 2 Inflammation in COPD?

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

Pulmonology

5 min

interactivity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

What Differentiates COPD Exacerbations From Asthma Exacerbations?

Pulmonology

2 min

expert video

What Differentiates COPD Exacerbations From Asthma Exacerbations?

The Heterogeneity of Underlying Inflammation in Patients With COPD

Pulmonology

2 min

expert video

The Heterogeneity of Underlying Inflammation in Patients With COPD

On demand event highlights

1 assets

ATS 2024 | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join leading experts for an educational symposium where they delve into the clinical consequences and real-world patient burden of type 2 inflammation in asthma and COPD.

3 assets

IRS-ISIAN 2024 | Evolving Perspectives in CRSwNP: From Symptom Control to Disease Remission

Presentation highlights from the ADVENT symposium on disease remission in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

5 assets

Lung Function White Board Videos

Explore our educational resources about the importance of lung function assessment in severe Adult and Pediatric Asthma.

3 assets

IRS-ISIAN 2024 | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Presentation highlights from the ADVENT symposium on smell loss and nasal congestion in CRSwNP at the 42nd Congress of the International Society of Inflammation and Allergy of the Nose and 24th Congress of the International Rhinologic Society in Tokyo, Japan.

9 assets

A Tale of Two Itches: Bridging the Gap With Type 2 Inflammation in PN and CSU

Drs. Elmariah, Kim, and Metz explore the latest research on neuro-immune mechanisms driving chronic itch and inflammation in PN and CSU.

3 assets

ADVENT at Diversity in Dermatology 2024 | Under the Skin: Considerations for Atopic Dermatitis and Prurigo Nodularis in Clinical Practice

Drs Sarina Elmariah and Mona Shahriari discuss the diagnostic considerations for atopic dermatitis and prurigo nodularis and uncover how clinical signs and itch in these diseases are impacted by type 2 inflammation.

13 assets

The Benefits of Early Intervention In AD: More Than Skin Deep

The following materials review the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient, improving clinical management and reducing long-term patient burden.

1 assets

Anosmia Awareness Day 2024

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Prof. Wytske Fokkens, Dr. Stella Lee, and Prof. Joaquim Mullol, among others.

3 assets

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

Drs. Stephen Rennard and Igor Barjaktarevic discuss the diverse clinical aspects of COPD, emphasizing the role of inflammation and the importance of biomarker assessments in guiding management strategies of recognizing the heterogeneity of COPD.

6 assets

World Congress on Itch 2023 Symposium: Itch in AD, PN, and CSU: Underlying Mechanisms and the Role of Type 2 Inflammation

Exploration of the shared mechanisms of itch across AD, PN, and CSU as well as the distinct ways itch manifests in each disease.

3 assets

Diving Below the Surface of Type 2 Inflammation in AD, PN, and CSU: Implications For Clinical Practice

Join Drs. James Del Rosso and Raj Chovatiya for an education program to explore the impact, contribution, and diagnosis of type 2 inflammation on atopic dermatitis, prurigo nodularis, and chronic spontaneous urticaria.

2 assets

ATS 2023 | Lower Airway Symposium | Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Join Prof. Klaus Rabe and Dr. Stephanie Christenson for the educational symposium on type 2 inflammation in COPD presented at ERS 2023.

11 assets

AAD Meeting 2023: Prurigo Nodularis and Atopic Dermatitis: Distinct Diseases With Shared and Unique Roles for Type 2 Inflammation

Highlights from the ADVENT symposium at AAD 2023 on the shared and unique roles of type 2 inflammation in atopic dermatitis and prurigo nodularis.

Explore all educational resources

Upcoming events

25September2024

Congress

ADVENT at EADV 2024

Join ADVENT at EADV 2024 congress (European Academy of Dermatology and Venereology) for 2 educational symposia on type 2 inflammation in atopic dermatitis and bullous pemphigoid. Visit Booth #A13 to learn more about type 2 inflammatory skin diseases with ADVENT. <p> </p> <div style="padding:56.25% 0 0 0;position:relative;"> <iframe style="height:100%;left:0;position:absolute;top:0;width:100%;" src="https://player.vimeo.com/video/992858886?title=0&byline=0&portrait=0 &badge=0&autopause=0&player_id=0&app_id=58479" frameborder="0" allow="autoplay; fullscreen; picture-in-picture; clipboard-write" title="ADVENT at EADV 2024"></iframe> </div> <script src=https://player.vimeo.com/api/player.js></script>

Future events

25September2024

Congress

ADVENT at EADV 2024

29September2024

Congress

ADVENT at IDS 2024 | Navigating the Complexities of Atopic Dermatitis and Prurigo Nodularis: A Clinical Toolkit for Practitioners

12October2024

Congress

ADVENT at UEG Week 2024

Hear from ADVENT experts

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region